Table 5. Multifactorial analysis of demographic and clinical characteristics in relation to CB2R cytoplasmic distribution, membranous distribution, and immunohistochemical score.
OR, odds ratio; CI, confidence interval; CB2R, cannabinoid type 2 receptor
| Reference category | CB2R cytoplasmic distribution | CB2R membranous | CB2R immunohistochemical score | ||||||||||
| OR | 95% CI | P-value | OR | 95% CI | P-value | OR | 95% CI | P-value | |||||
| Age | - | 0.97 | 0.92 | 103 | 0.367 | 1.01 | 0.96 | 1.05 | 0.821 | 1.03 | 0.99 | 1.07 | 0.190 |
| Gender (male) | Female | 3.59 | 0.86 | 15.00 | 0.080 | 1.89 | 0.54 | 6.55 | 0.317 | 2.56 | 0.83 | 7.89 | 0.103 |
| Grade | 0.093 | 0.621 | 0.639 | ||||||||||
| 2 | 1 | 0.66 | 0.10 | 4.40 | 0.669 | 0.65 | 0.08 | 4.99 | 0.678 | 0.61 | 0.16 | 2.26 | 0.456 |
| 3 | 5.01 | 0.46 | 54.94 | 0.187 | 0.40 | 0.05 | 3.33 | 0.397 | 0.94 | 0.22 | 3.98 | 0.928 | |
| Stage Τα | 0.946 | 0.539 | 0.947 | ||||||||||
| 2 | 1 | 1.38 | 0.11 | 16.84 | 0.802 | 0.55 | 0.10 | 3.00 | 0.487 | 1.02 | 0.24 | 4.33 | 0.974 |
| 3 | 0.83 | 0.11 | 6.18 | 0.855 | 0.45 | 0.10 | 2.14 | 0.313 | 0.80 | 0.19 | 3.29 | 0.752 | |
| Histologic type | 0.374 | <0.0005 | 0.053 | ||||||||||
| Papillary | Clear cell | 3.83 | 0.39 | 37.48 | 0.249 | 0.03 | 0.0 | 0.16 | <0.0005 | 1.12 | 0.35 | 3.57 | 0.854 |
| Chromophobe | 3.03 | 0.27 | 33.74 | 0.368 | 0.65 | 0.14 | 3.08 | 0.588 | 5.90 | 1.15 | 30.23 | 0.033 | |